Federal Hearing On COVID-19 Response
7am PT | 10am EST
Chairs Rodgers, Griffith, and Guthrie Announce Joint Oversight & Investigations Subcommittee and Health Subcommittee Hearing on COVID-19 Response
Members Request Testimony from CDC, FDA, NIH, and ASPR
Washington, D.C. — House Energy and Commerce Committee Chair Cathy McMorris Rodgers (R-WA), Oversight and Investigations Subcommittee Chair Morgan Griffith (R-VA), and Health Subcommittee Chair Brett Guthrie (R-KY) today announced a joint hearing of the Oversight and Investigations and Health subcommittees. It will focus on the federal government’s response to the COVID-19 pandemic.
“With more than one million Americans lost to the pandemic and our government health agencies having lost the American public’s trust due to misguided mandates and lockdowns, it’s critical to thoroughly examine all aspects of the pandemic response. This is the first of a series of hearings and investigations that our committee will conduct. It’s imperative that we hear from these government health agencies to uncover what decisions were made and why, hold individuals accountable for errors, bolster our pandemic preparedness moving forward, and start on the long road to rebuilding public trust in our institutions.”
Joint Subcommittee on Oversight and Investigations and Subcommittee on Health Hearing Titled: “The Federal Response to COVID-19.”
WHAT: A hearing to examine and discuss the past, present, and future of the federal response to COVID-19.
DATE: Wednesday, February 8, 2023
TIME: 10:00 AM ET
LOCATION: 2123 Rayburn House Office Building
Dr. Lawrence A. Tabak, D.D.S., PhD., Senior Official Performing the Duties of the Director, National Institutes of Health The Honorable Robert Califf, M.D., Commissioner of Food and Drugs, U.S. Food and Drug Administration Dr. Rochelle P. Walensky, M.D., M.P.H., Director, Centers for Disease Control and Prevention The Honorable Dawn O’Connell, Assistant Secretary for Preparedness and Response, U.S. Department of Health and Human Services